分析应用神经内镜下颅内血肿清除术治疗颅内血肿的临床效果

Objective To explore the clinical effect of intracranial hematoma removal under neuroendoscope in the treatment of intracranial hematoma. Methods During the period from January 2021 to February 2024, the samples of patients who participated in the study were selected, and the source of the samples was 50 patients with supratentorial hematoma whose intracranial hematoma was between 20 mL～40 mL, which was indicated by head CT in our hospital. The above patients were randomly divided into two groups: the traditional group(25 cases, who underwent craniotomy to remove intracranial hematoma) and the research group(25 cases, who underwent neuroendoscopic intracranial hematoma removal). After the treatment, the clinical indexes of the two groups were compared in detail. Results The data of operation time and hospitalization time, complication rate, neurological and quality of life scores and clinical indexes of patients in the research group were better than those in the traditional group(P<0.05). Conclusion Neuroendo scopic removal of intracranial hematoma has obvious clinical advantages in the treatment of intracranial hematoma, which can effectively shorten the operation time and hospitalization time, reduce the incidence of complications, promote the recovery of neurological function, improve the quality of life and improve clinical indicators. It is suggested that neuroendoscopic intracranial hematoma removal should be popularized in clinical practice to provide better treatment options for patients with intracranial hematoma.